日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Engineering a "muco-trapping" ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19

构建一种具有皮摩尔级亲和力的“粘液捕获”ACE2-免疫球蛋白杂合物，作为吸入式、泛变异型COVID-19免疫疗法

期刊:Bioengineering & Translational Medicine
影响因子:6.1
doi:10.1002/btm2.10650
Karthik Tiruthani ,Carlos Cruz-Teran ,Jasper F W Chan ,Alice Ma ,Morgan McSweeney ,Whitney Wolf ,Shoufeng Yuan ,Vincent K M Poon ,Chris C S Chan ,Lakshmi Botta ,Brian Farrer ,Ian Stewart ,Alison Schaefer ,Jasmine Edelstein ,Priya Kumar ,Harendra Arora ,Jeff T Hutchins ,Anthony J Hickey ,Kwok-Yung Yuen ,Samuel K Lai
ACE2
免疫/内分泌
发表日期：2024
文献求助 收藏

Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice

Siglec15/TGF-β双特异性抗体介导小鼠对4T1三阴性乳腺癌的协同抗肿瘤反应

期刊:Bioengineering & Translational Medicine
影响因子:6.1
doi:10.1002/btm2.10651
Limei Shen ，Alison M Schaefer ，Karthik Tiruthani ，Whitney Wolf ，Samuel K Lai
肿瘤
TGF-β
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium

mAb-FcRn 亲和力对 IgG 跨人类分化良好的气道上皮细胞转胞吞的影响

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2024.1371156
Kohei Togami, Whitney Wolf, Lucas C Olson, Madison Card, Limei Shen, Alison Schaefer, Kenichi Okuda, Larry Zeitlin, Michael Pauly, Kevin Whaley, Raymond J Pickles, Samuel K Lai
免疫
细胞生物学
上皮细胞
发表日期：2024
文献求助 收藏

Inhaled "Muco-Trapping" Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections

吸入式“粘膜捕获”单克隆抗体可有效治疗已确诊的呼吸道合胞病毒 (RSV) 感染

期刊:Advanced Science
影响因子:
doi:10.1002/advs.202306729
Morgan D McSweeney, Sarhad Alnajjar, Alison M Schaefer, Zach Richardson, Whitney Wolf, Ian Stewart, Pun Sriboonyapirat, Justin McCallen, Ellen Farmer, Bernadette Nzati, Sam Lord, Brian Farrer, Thomas R Moench, Priya A Kumar, Harendra Arora, Raymond J Pickles, Anthony J Hickey, Mark Ackermann, Samuel
微生物学
发表日期：2024
文献求助 收藏

Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19

regdanvimab/IN-006 具有稳定的雾化性和黏液捕获特性，支持其开发成为一种强效、低剂量的 COVID-19 吸入疗法。

期刊:Bioengineering & Translational Medicine
影响因子:6.1
doi:10.1002/btm2.10391
Morgan D McSweeney ,Ian Stewart ,Zach Richardson ,Hyunah Kang ,Yoona Park ,Cheolmin Kim ,Karthik Tiruthani ,Whitney Wolf ,Alison Schaefer ,Priya Kumar ,Harendra Aurora ,Jeff Hutchins ,Jong Moon Cho ,Anthony J Hickey ,Soo Young Lee ,Samuel K Lai
发表日期：2022
文献求助 收藏